Diseases of the Pleura

Preview:

DESCRIPTION

Target: UG medical students.

Citation preview

DISEASES OF THE PLEURA

Dr.CSBR.Prasad, M.D.

CSBRP-Dec-2012

PLEURA

Normal data: --- 15 ml, serous, clear fluid --- Helps in lubrication --- Visceral & Parietal pleura --- Has mesothelial covering --- Mets more common than primary tumors

CSBRP-Dec-2012

Pleural Effusion

CSBRP-Dec-2012

Pleural effusion - Mechanisms

• Hydrostatic pressure - CHF

• Vascular permeability - Pneumonia

• Oncotic pressure - Nephrotic syndrome

• Negative intrapleural pressure - Atelectasis

• Lymphatic drainage - Carcinomatosis

CSBRP-Dec-2012

Nephrotic syndrome

CSBRP-Dec-2012

CHF – Cardiomegaly & Pleural effusion

CSBRP-Dec-2012

Pneumonia

CSBRP-Dec-2012

Pneumonia with effusion

CSBRP-Dec-2012

Pneumonia with effusion

CSBRP-Dec-2012

Carcinomatosis

CSBRP-Dec-2012

Lymphangitis carcinomatosa

CSBRP-Dec-2012

Lymphangitis carcinomatosanomatosa

CSBRP-Dec-2012

A nest of malignant cells is seen in a dilated lymphatic

channel causing complete occlusion

Inflammatory Pleural Effusions:

• Serofibrinous pleuritis

• Suppurative pleuritis

• Hemorrhagic pleuritis

CSBRP-Dec-2012

Serofibrinous pleuritis

• Pulmonary inflammation:

– TB

– Pneumonia

– Infarcts

– Abscess

• Systemic disease: – Rheumatoid arthritis

– Uremia

CSBRP-Dec-2012

Suppurative pleuritis

• Empyema

• Pleural space infection

CSBRP-Dec-2012

Hemorrhagic pleuritis

• Bleeding disorders

• Mets

• Rickettssial diseases

• TB

CSBRP-Dec-2012

Purulent pleural effusions: [Empyema]

Causes:

Bacterial or mycotic seedling of pleura

* Commonly contiguous spread

* Lymphatic or blood dissemination

* Sympathetic effusion: Primary liver abscess

CSBRP-Dec-2012

Non-inflammatory Pleural Effusions:

Hydrothorax:

• Straw-colored

• Common cause - Cardiac failure

Hemothorax:

• Ruptured aortic aneurysms

• Vascular trauma

Chylothorax:

• Lymphatic obstruction / rupture

CSBRP-Dec-2012

Chylothorax

• Milky fluid

• Finely emulsified fat

• Often unilateral

• Thoracic duct trauma / obstruction

• Malignant conditions of thoracic cavity

• Thoracic duct involvement by mets

High Triglycerides

CSBRP-Dec-2012

Chylothorax

Right sided pleural effusion

• Associated with ascites from any cause

• Pressure gradient b/n peritoneal and pleural cavities - favor movement of fluid - across lymphatics

Don’t forget Meig’s syndrome

CSBRP-Dec-2012

Meig’s syndrome

• Ovarian fibroma

• Right sided pleural effusion

• Ascitis

CSBRP-Dec-2012

Pneumothorax

CSBRP-Dec-2012

Pneumothorax

• Air or gas in pleural cavities

• Spontaneous, traumatic, therapeutic

• Associated with emphysema, asthma, tuberculosis

CSBRP-Dec-2012

Spontaneous idiopathic Pneumothorax

• Young

• Rupture of small, peripheral, usually apical subpleural blebs

• Subsides spontaneously with air absorption

• Recurrent, disabling

CSBRP-Dec-2012

Complications - Pneumothorax

• Compression

• Collapse

• Atelectasis

• When defect acts as flap valve- one way entry of air-progressively increases pressure -TENSION PNEUMOTHORAX

CSBRP-Dec-2012

Tumors of the Pleura

CSBRP-Dec-2012

Pleural Tumors

• Primary tumors - rare

• Secondary tumors - [Metastatic ] from

lung, breast, Ovary

Primary Pleural tumors: 1. Benign (SFT, Benign Mesothelioma)

2. Malignant (Pri. Effusion Lymphoma)

CSBRP-Dec-2012

Carcinoma of breast metastasizing to pleura

CSBRP-Dec-2012

Tumor embolus in a lymphatic CSBRP-Dec-2012

Solitary Fibrous Tumor

• Also called = Benign mesothelioma,

= Pleural fibroma

• Localized growth - 1 - 2 cms,

• Do not produce effusion,

• Gross: Dense fibrous tissues with cysts

• Micro: Whorls of collagen fibers.

Benign Pleural Tumors:

CSBRP-Dec-2012

Malignant Mesothelioma:

• Origin --- parietal or visceral pleura

• Uncommon [Frequency is 0.9 cases per 100,000 persons]

• 90% associated with asbestos exposure

• Latent period = 25 to 45 years

• No additional risk with smoking

• Life time risk = 7-10% (with asbestosis)

• Asbestos workers who smoke tend to die of Bronchogenic carcinoma than mesothelioma

CSBRP-Dec-2012

Exposure to asbestos linked to:

1. Fibrous plaque - localized or diffuse

2. Pleural effusions

3. Interstitial fibrosis [ asbestosis ]

4. Bronchogenic carcinoma,

5. Mesothelioma

6. Laryngeal and other neoplasm

including carcinoma colon

CSBRP-Dec-2012

Markers of asbestos exposure:

• Asbestos bodies in the lung tissue

• Pleural plaques

CSBRP-Dec-2012

Pleural plaques

CSBRP-Dec-2012

Fibrous pleural plaque

CSBRP-Dec-2012

Diffuse visceral

Pleural fibrosis

CSBRP-Dec-2012

CSBRP-Dec-2012

CSBRP-Dec-2012

Cytogenetics:

• Seen in 60-80% of tumors

• Deletion in 1p, 3p, 6q, 22q

• p53 mutations

• SV40 viral DNA (inactivate p53, RB genes)

CSBRP-Dec-2012

Morphology - gross:

• Diffuse lesion spreads widely along the pleural surface

• Pleural effusion

• Invasion of thoracic wall

• Encasement of lung by the pleural tumor

Rapidly accumulating

pleural effusion

CSBRP-Dec-2012

Mesothelioma

Encased lung in Mesothelioma CSBRP-Dec-2012

Encased lungs in Mesothelioma

Encased lung in Mesothelioma

Microscopy:

• Sarcomatoid type

• Epithelial type

Distinguished from adenocarcinomas

= Acid mucopolysaccharides - positive

= CEA - negative

= Keratin - positive (perinuclear)

= Calretinin - Positive

= EM - long microvilli

• Mixed type – Biphasic type CSBRP-Dec-2012

CSBRP-Dec-2012

CSBRP-Dec-2012

CSBRP-Dec-2012

Clinical features:

• Chest pain

• Dyspnea

• Rapidly filling pleural effusion

• Mets in Hilar LNs, Liver, chest wall

CSBRP-Dec-2012

CSBRP-Dec-2012

Superior

venacaval

syndrome

Superior venacaval syndrome

Photographs of the patient showing the reduction in swelling of the

face, neck and upper extremities

(A) At initial presentation and (B) after treatment (hospital day 8)

Clinical features:

Prognosis:

50% die with in 12 months

of diagnosis.

CSBRP-Dec-2012

Other sites:

Mesothelioma can also arise in:

… Peritoneum

… Pericardium

… Tunica vaginalis

CSBRP-Dec-2012

Mesothelioma of the pericardium

E N D

CSBRP-Dec-2012

Recommended